These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 222445)

  • 1. Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement.
    Lo TN; Boyle MD
    Cancer Res; 1979 Aug; 39(8):3156-62. PubMed ID: 222445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1979 Dec; 63(6):1475-83. PubMed ID: 292816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.
    Schlager SI; Ohanian SH
    Cancer Res; 1979 Apr; 39(4):1369-76. PubMed ID: 421220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3204-8. PubMed ID: 52405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1276-9. PubMed ID: 178794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic requirements for hormone-induced resistance to antibody-complement mediated killing of tumor cells.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1977 Sep; 119(3):789-94. PubMed ID: 894026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Mar; 116(3):661-8. PubMed ID: 176270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between intracellular cyclic AMP level and cytotoxic sensitivity to anti-tumor-associated antigen antibody in rat fibrosarcoma cells].
    Saito T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):882-8. PubMed ID: 2854817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metabolic inhibitors on killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1411-3. PubMed ID: 4372384
    [No Abstract]   [Full Text] [Related]  

  • 18. New monoclonal antibodies specific for the guinea pig line 10 hepatocarcinoma.
    Kataoka T; Chiba J; Ohnuki T; Nemoto K; Tokunaga T
    Jpn J Cancer Res; 1987 Sep; 78(9):960-7. PubMed ID: 3117752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in H35 hepatoma and Chinese hamster ovary cells by a phorbol ester tumor promoter.
    Byus CV; Trevillyan JM; Cavit LJ; Fletcher WH
    Cancer Res; 1983 Jul; 43(7):3321-6. PubMed ID: 6303580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the tumor promotor 12-o-tetradecanoyl phorbol-13--acetate on cyclic adenosine monophosphate levels in cell cultures. Relation to cell proliferation].
    Ganelina LSh; Ignatova TN; Pashinin IuV
    Tsitologiia; 1983 Nov; 25(11):1296-301. PubMed ID: 6318411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.